Travere Therapeutics, Inc.Travere Therapeutics, Inc.Travere Therapeutics, Inc.

Travere Therapeutics, Inc.

No trades
See on Supercharts

Price target

15.000.00 0.00%
The 15 analysts offering 1 year price forecasts for TVTX have a max estimate of — and a min estimate of —.

Analyst rating

Based on 16 analysts giving stock ratings to TVTX in the past 3 months.

EPS

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise

Revenue

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions

TVTX EPS for the last quarter is −1.18 USD despite the estimation of −1.16 USD. In the next quarter EPS is expected to reach −0.94 USD. Track more of Travere Therapeutics, Inc. financials and stay on top of what is up with the company.
In the next quarter Travere Therapeutics, Inc. revenue is expected to reach ‪43.46 M‬ USD. Check out Travere Therapeutics, Inc. revenue and earnings and make informed decisions.
According to analysts, TVTX price target is 15.00 USD with a max estimate of 21.00 USD and a min estimate of 9.00 USD. Check if this forecast comes true in a year, meanwhile watch Travere Therapeutics, Inc. stock price chart and keep track of the current situation with TVTX news and stock market news.
We've gathered opinions of 16 analysts rating TVTX stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as buy. Note that it's not a trading advice — your own analysis is still required.